SB
Samsara BioCapital Portfolio holdings
AUM
$489M
1-Year Return
135.25%
This Quarter Return
+31.17%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$570M
AUM Growth
+$85.9M
(+18%)
Cap. Flow
-$9.28M
Cap. Flow
% of AUM
-1.63%
Top 10 Holdings %
Top 10 Hldgs %
79.11%
Holding
57
New
1
Increased
2
Reduced
9
Closed
10
Top Buys
| 1 |
SLRN
ACELYRIN
SLRN
|
$47.2M |
| 2 |
Lyra Therapeutics
LYRA
|
$4.12M |
| 3 |
Leap Therapeutics
LPTX
|
$1.62M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$14.9M |
| 2 |
Arcellx
ACLX
|
$9.35M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$7.35M |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$7.28M |
| 5 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$6.52M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
51
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| – | – |
-13,669
| Closed | -$55.8K |
|
|
BCEL
52
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| – | – |
-262,827
| Closed | -$300K |
|
|
AMYT
53
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| – | – |
-304,715
| Closed | -$4.44M |
|
54
ALX Oncology
ALXO
$56.8M
| – | – |
-262,786
| Closed | -$1.19M |
|
|
CNTA
55
Centessa Pharmaceuticals
CNTA
$2.12B
| – | – |
-1,693,736
| Closed | -$6.52M |
|
56
Equillium
EQ
$65M
| – | – |
-615,541
| Closed | -$449K |
|
|
INZY
57
DELISTED
Inozyme Pharma
INZY
| – | – |
-504,407
| Closed | -$2.89M |
|